Settings

Sidenav Mini

Light/Dark

MONEY Tuesday January 25th 2022 Morning Stock Newsletter


🌟🌟 Good morning Team and Happy Tuesday  🌟🌟

Welcome back to the BEST Trading Chatroom in the WORLD 😎 I hope you all had an awesome evening and that you are ready to rock and roll on this beautiful Tuesday! 

Yesterday was an AMAZING day in the market and inside of chat πŸ‘πŸ‘πŸ‘ We absolutely crushed in once again and are seeing a fantastic start to 2022 from all traders.

Let’s keep this momentum and consistency going for the rest of this week and let’s see our BIGGEST month yet! πŸ”₯

Get πŸ”₯ FIRED πŸ”₯up team because we are hitting it hard today.


STOCKS WITH NEWS

The Fed is likely to signal a March interest rate hike and that further policy tightening is coming  https://www.cnbc.com/2022/01/25/the-federal-reserve-is-likely-to-signal-a-march-rate-hike.html

$CAAS China Automotive Systems Signs Supply Contract with SCANIA https://newsfilter.io/a/5c94ec96d26bc45edae079378836e673

$NXPL NextPlat’s Global Telesat Communications Subsidiary Announces Global Reseller and Marketing Agreement with Blue Sky Network https://newsfilter.io/a/3d04eb4cbf0b3b7273de3fbf98e5cdc4

$SLI Standard Lithium Signs Letter of Intent With Koch Minerals & Trading for Lithium Off-Take and Key Raw Material Procurement https://newsfilter.io/a/f03437bf926f71a1ab3416e86371f1ea

$SRRAΒ – Sierra Oncology Announces Momelotinib Achieved Statistically Significant Benefit on Symptoms, Anemia and Splenic Size in the Pivotal MOMENTUM Study for Myelofibrosis –Β https://finance.yahoo.com/news/sierra-oncology-announces-momelotinib-achieved-120000858.html

$CKPT Checkpoint Therapeutics Announces Positive Topline Results from the Registration-Enabling Trial of Cosibelimab in Metastatic Cutaneous Squamous Cell Carcinoma https://finance.yahoo.com/news/checkpoint-therapeutics-announces-positive-topline-123000878.html

$TRQ Oyu Tolgoi partners reach comprehensive agreement and approve commencement of underground mining operations https://newsfilter.io/a/ae8a88c7e6bdcbfeb4e04825cb3ab555

$CBIO Catalyst Biosciences Receives Rare Pediatric Disease Designation for CB 4332 for the Treatment of CFI Deficiency https://www.stocktitan.net/news/CBIO/catalyst-biosciences-receives-rare-pediatric-disease-designation-for-akcg1c6vum2k.html


PRE MARKET GAPPERS


PRIOR DAY TOP GAINERS


Earnings this Week